Children's Tumor Foundation Expands into a New Strategic Chapter as Impact Investor in NF Research
New York, NY (PRWEB) January 10, 2023 -- - Makes major investment in Phase 2b Clinical Trial at NFlection Therapeutics- Topical MEK inhibitor NFX-179 Shows
Annette Bakker Wilson Sonsini Goodrich Rosati Alex Zisson Randall Stanicky Alexion Astrazeneca Gabriel Groisman
Source: prweb.com